Fig. 1From: Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screeningAnalysis workflow and sample statistics. a Overview of analysis workflow. b Distribution of the number of samples for each of ten cancers screened for biomarkers prognostic for survival. c Characteristics of samples used in the process of identifying stage-specific KIRC biomarkers. Abbreviations for cancer names were provided in the main textBack to article page